药理学
脂多糖
半乳糖胺
肝损伤
细胞凋亡
腹腔注射
上睑下垂
炎症
化学
医学
程序性细胞死亡
生物化学
免疫学
氨基葡萄糖
作者
Adrian S. Siregar,Marie Merci Nyiramana,Eun‐Jin Kim,Soo Buem Cho,Min Seok Woo,Dong‐Kun Lee,Seong-Geun Hong,Jaehee Han,Sang Soo Kang,Deok Ryong Kim,Yeung Joon Choi,Dawon Kang
出处
期刊:Marine Drugs
[Multidisciplinary Digital Publishing Institute]
日期:2021-10-28
卷期号:19 (11): 614-614
被引量:46
摘要
Models created by the intraperitoneal injection of lipopolysaccharide (LPS) and D-galactosamine (D-GalN) have been widely used to study the pathogenesis of human acute liver failure (ALF) and drug development. Our previous study reported that oyster (Crassostrea gigas) hydrolysate (OH) had a hepatoprotective effect in LPS/D-GalN-injected mice. This study was performed to identify the hepatoprotective effect of the tyrosine-alanine (YA) peptide, the main component of OH, in a LPS/D-GalN-injected ALF mice model. We analyzed the effect of YA on previously known mechanisms of hepatocellular injury in the model. LPS/D-GalN-injected mice showed inflammatory, apoptotic, ferroptotic, and pyroptotic liver injury. The pre-administration of YA (10 mg/kg or 50 mg/kg) significantly reduced the liver damage factors. The hepatoprotective effect of YA was higher in the 50 mg/kg YA pre-administered group than in the 10 mg/kg YA pre-administered group. These results showed that YA had a hepatoprotective effect by reducing inflammation, apoptosis, ferroptosis, and pyroptosis in the LPS/D-GalN-injected ALF mouse model. We suggest that YA can be used as a functional peptide for the prevention of acute liver injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI